Income Statement
LUNAI BIOWORKS INC.
LNAI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Jun 30, 2025 2025 FY | Jun 30, 2024 2024 FY | Jun 30, 2023 2023 FY | Jun 30, 2022 2022 FY | Jun 30, 2021 2021 FY | Jun 30, 2020 2020 FY | Jun 30, 2019 2019 FY | Jun 30, 2018 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Dec 31, 2014 2014 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - | 0.00 | 0.00 | 0.00 | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | - | 0.04 | -0.30 | - | - |
|
Operating Expenses
|
188.97 | 81.64 | 38.56 | 116.08 | 23.40 | 11.92 | 10.99 | 8.17 | 2.65 | 2.16 | 2.13 | 0.04 | 0.03 |
|
Research & Development
|
0.54 | 2.71 | 4.17 | 8.37 | 15.54 | 4.69 | 2.50 | 0.62 | 0.06 | 0.80 | - | - | - |
|
Selling, General & Administrative
|
17.88 | 24.56 | 15.32 | 14.33 | 7.74 | 7.12 | 8.27 | 3.64 | 1.56 | 1.23 | 1.64 | 0.04 | 0.03 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-188.97 | -81.64 | -38.56 | -116.08 | -23.40 | -11.92 | -10.99 | -8.17 | -2.65 | -2.12 | -2.43 | -0.04 | -0.03 |
|
Non-Operating Income
|
10.96 | 0.99 | -1.13 | 2.65 | -3.45 | 0.51 | -7.03 | 1.01 | 0.19 | -0.08 | -0.12 | 0.00 | 0.00 |
|
Interest Income
|
- | - | - | 0.12 | 0.01 | 0.05 | 0.07 | 0.05 | - | - | 0.01 | - | - |
|
Interest Expense
|
- | 0.03 | 0.58 | 0.37 | 0.38 | 0.10 | 0.00 | - | - | 0.00 | 0.08 | 0.00 | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | -39.68 | -113.43 | -26.85 | -11.42 | -18.02 | -9.26 | -2.46 | -2.20 | -2.55 | -0.04 | -0.03 |
|
Income Tax Expense
|
- | - | 0.00 | 0.00 | -0.13 | 0.00 | - | -0.11 | -0.06 | -0.46 | -0.18 | 0.00 | -0.03 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-178.01 | -80.65 | -39.68 | -113.43 | -26.72 | -11.42 | 18.02 | -9.15 | -2.39 | -1.74 | 2.37 | -0.04 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Jun 30, 2025 2025 FY | Jun 30, 2024 2024 FY | Jun 30, 2023 2023 FY | Jun 30, 2022 2022 FY | Jun 30, 2021 2021 FY | Jun 30, 2020 2020 FY | Jun 30, 2019 2019 FY | Jun 30, 2018 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Dec 31, 2014 2014 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-188.84 | -81.52 | -38.44 | -115.96 | -23.28 | -11.82 | -10.92 | -5.31 | -2.64 | -2.09 | -2.41 | -0.04 | -0.03 |
|
Earnings Per Share (Basic)
|
-1.08 | -0.84 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-1.08 | -0.84 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
165.06 | 96.25 | - | - | - | - | - | - | 12.27 | 9.53 | - | - | - |
|
Diluted Weighted Avg Shares
|
165.06 | 96.25 | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-167.02 | -80.79 | -39.68 | -113.45 | -26.69 | -11.60 | -18.12 | -9.30 | -2.60 | -1.71 | -2.06 | - | - |